L'Oréal, a beauty company, led a $34m Series B round in Debut, an integrated synthetic biology company, with participation from Fine Structure Ventures, Material Impact, GS Futures, Cavallo Ventures, Cultivian Sandbox Ventures, and ACVC Partners. "Debut exists to set a new standard in beauty by developing novel active ingredients that herald a new era with regard to performance, sustainability, scalability and cost, and we are thrilled to be partnering with L'Oréal's BOLD, the beauty world leader that is as invested in this industry's future as we are. Everyday, we are leveraging our team's groundbreaking technology, scientific research and unbridled creativity to lead the biological revolution that will transform beauty as we know it. We harness synthetic biology to create novel and higher-performing ingredients that are not accessible by other means in order to advance product benefits and target unmet consumer needs," Joshua Britton, Debut Founder and CEO.